Getein Biotech, Inc

    Jurisdiction
    China
    ISIN
    CNE100002RR9 (603387.SS)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    6 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    1 / 7

    Profile

    Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic products in China and internationally. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €127.65M
    Gross margin
    69.3%
    EBIT
    €27.90M
    EBIT margin
    21.9%
    Net income
    €25.60M
    Net margin
    20.1%

    Statement period: - (published )

    Dividends

    Last dividend amount
    CN¥0.09
    Ex date
    Payment date
    Dividend payout ratio
    49.2%

    Add to watchlist

    Notifications